Latest Breaking News On - Metastatic malignant urachal - Page 1 : comparemela.com

ASCO 2024 results of a multicenter phase II trial of modified FOLFIRINOX for the first-line treatment of advanced urachal cancer (ULTMA; KCSG GU20-03), Urachal cancer is a rare malignancy accounting for 1% of bladder cancers.

United statesSouth koreaSoult ukpyolsiJae lyun leeMd anderson cancer centerSociety of urologic oncologyAmerican society of clinical oncologyUniversity college of medicineAsan medical centerUniversity of torontoClinical oncologyAnnual meetingUniversity collegeRashid sayyidUrologic oncologyClinical fellow